Adequacy and consistency of animal studies to evaluate the neurotoxicity of chronic low-level manganese exposure in humans

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 70, Issue 7, 2007, Pages 594-605

  Gwiazda, Roberto ^a   Lucchini, Roberto ^b   Smith, Donald ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; MANGANESE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; ENVIRONMENTAL EXPOSURE; FEMALE; GABAERGIC TRANSMISSION; GLOBUS PALLIDUS; INTOXICATION; MALE; MOTOR DEVELOPMENT; MOTOR PERFORMANCE; NEUROCHEMISTRY; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PUTAMEN;

ANIMALS; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; GAMMA-AMINOBUTYRIC ACID; HAPLORHINI; HUMANS; MANGANESE; MANGANESE POISONING; NERVOUS SYSTEM; RECEPTORS, DOPAMINE; RISK ASSESSMENT; SPECIES SPECIFICITY; TOXICITY TESTS;

ANIMALIA; PRIMATES; RODENTIA;

EID: 33847247860     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/10937400600882897     Document Type: Article

References (111)

1. Agency for Toxic Substances and Disease Registry. 2000. Toxicological profile for manganese (update). Atlanta, GA: U.S. Department of Health and Human Services.
2. Ardeleanu, A., Loranger, S., Kennedy, G., L'Espérance, G., and Zayed, Z. 1999. Emission rates and physico-chemical characteristics of Mn particles emitted by vehicles using methylcyclopentadienly manganese tricarbonyl (MMT) as an octane improver. Water Air Soil Pollut. 115:411-427.
3. Arnich, N., Cunat, L., Lanhers, M. C., and Burnel, D. 2004. Comparative in situ study of the intestinal absorption of aluminum, manganese, nickel, and lead in rats. Biol. Trace Elem. Res. 99:157-171.
4. Autissier, N., Rochette, L., Dumas, P., Beley, A., Loireau, A., and Bralet, J. 1982. Dopamine and norepinephrine turnover in various regions of the rat brain after chronic manganese chloride administration. Toxicology 24:175-182.
5. Baldwin, M., Mergler, D., Larribe, F., Belanger, S., Tardif, R., Bilodeau, L., and Hudnell, K. 1999. Bioindicator and exposure data for a population based study of manganese. Neurotoxicology 20:343-353.
6. Beuter, A., Edwards, R. deGeoffroy, A., Mergler, D., and Hudnell, K. 1999. Quantification of neuromotor function for detection of the effects of manganese. Neurotoxicology 20:355-366.
7. Bird, E. D., Anton, A. H., and Bullock, B. 1984. The effect of manganese inhalation on basal ganglia dopamine concentrations in rhesus monkey. Neurotoxicology 5:59-65.
8. Blumberg, K., and Walsh, M. P. 2004. Status report concerning the use of MMT in gasoline. International Council on Clean Transportation. http://www.healthandcleanair.org/mmt/icct.pdf
9. Bonilla, E. 1978. Increased GABA content in caudate nucleus of rats after chronic manganese chloride administration. J. Neurochem. 31:551-552.
10. Bonilla, E. 1984. Chronic manganese intake induces changes in the motor activity of rats. Exp. Neurol. 84:696-700.
11. Bonilla, E., and Prasad, A. L. 1984. Effects of chronic manganese intake on the levels of biogenic amines in rat brain regions. Neurobehav. Toxicol. Teratol. 6:341-344.
12. Bonilla, E., Arrieta, A., Castro, F., Davila, J. O., and Quiroz, I. 1994. Manganese toxicity: free amino acids in the striatum and olfactory bulb of the mouse. Invest. Clin. 35:175-181.
13. Bourne, H. G. 1975. The rhesus monkey. Vol. I, Anatomy and physiology. New York: Academic Press.
14. Bowler, R. M., Mergler, D., Sassine, M. P., Larribe, F., and Hudnell, K. 1999. Neuropsychiatric effects of manganese on mood. Neurotoxicology 20:367-378.
15. 2) to the rat brain: Toxicokinetic investigations in a unilateral nasal occlusion model. Toxicol. Appl. Pharmacol. 169:238-248.
16. Bull, R. J. 1978. Parodoxical decrease in corpus striatal manganese concentrations with manganese load. Commun. Psychopharmacol. 2:17-20.
17. Calabresi, P., Ammassari-Teule, M., Gubellini, P., Sancesario, G., Morello, M., Centonze, D., Marfia, G. A., Saulle, E., Passino, E., Picconi, B., and Bernardi, G. 2001. A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication. Neurobiol. Dis. 8:419-432.
18. Calne, D. B., Chu, N. S., Huang, C. C., Lu, C. S., and Olanow, W. 1994. Manganism and idiopathic parkinsonism: Similarities and differences. Neurology 44:1583-1586.
19. Chandra, S. V. 1983. Psychiatric illness due to manganese poisoning. Acta Psychiatr. Scand. Suppl. 303:49-54.
20. Chandra, S. V., and Shukla, G. S. 1981. Concentrations of striatal catecholamines in rats given manganese chloride through drinking water. J. Neurochem. 36:683-687.
21. Chandra, S. V., Shukla, G. S., Srivastava, R. S., Singh, H., and Gupta, V. P. 1981. An exploratory study of manganese exposure to welders. Clin. Toxicol. 18:407-416.
22. Cotzias, G. C., Miller, S. T., Papavasiliou, P. S., Tang, L. C. 1976. Interactions between manganese and brain dopamine. Med. Clin. North Am. 60:729-738.
23. Couper, J. 1837. On the effects of black oxide of manganese when inhaled into the lungs. Br. Ann. Med. Pharmacol. Vital Stat. Gen. Sci. 1:41-42.
24. Davis, J. M., Jarabek, A. M., Mage, D. T., and Graham, J. A. 1998. The EPA health risk assessment of methylcyclopentadienyl manganese tricarbonyl (MMT). Risk Anal. 18:57-70.
25. Dorman, D. C., Struve, M. F., Arden, J. R., Marshall, M. W., Parkinson, C. U., Wong, B. A. 2001. Influence of particle solubility on the delivery of inhaled manganese to the rat brain: Manganese sulfate and manganese tetroxide pharmacokinetics following repeated (14 day) exposure. Tox. and App. Pharm. 170:79-87.
26. Dorman, D. C., Brenneman, K. A., McElveen, A. M., Lynch, S. E., Roberts, K. C., and Wong, B. A. 2002. Olfactory transport: A direct route of delivery of inhaled manganese phosphate to the rat brain. J. Toxicol. Environ. Health A 65:1493-1511.
27. Dorman, D. C., McManus, B. E., Parkinson, C. U., Manuel, C. A., McElveen, A. M., and Everitt, J. I. 2004. Nasal toxicity of manganese sulfate and manganese phosphate in young male rats following subchronic (13-week) inhalation exposure. Inhal. Toxicol. 16:481-488.
28. Dorman, D. C., McElveen, A. M., Marshall, M. W., Parkinson, C. U., James, R. A., Struve, M. F., and Wong, B. A. 2005. Tissue manganese concentrations in lactating rats and their offspring following combined in utero and lactation exposure to inhaled manganese sulfate. Toxicol. Sci. 84:12-21.
29. Egyed, M., and Wood, G. C. 1996. Risk assessment for combustion products of the gasoline additive MMT in Canada. Sci. Total Environ. 190:11-20.
30. Eriksson, H., Lenngren, S., and Heilbronn, E. 1987a. Effect of long-term administration of manganese on biogenic amine levels in discrete striatal regions of rat brain. Arch. Toxicol. 59:426-431.
31. Eriksson, H., Mägiste, K., Plantin, L. O., Fonnum, F., Hedström K. G., Theodorsson-Norheim, E., Kristensson, K., Stålberg, E., and Heilbronn, E. 1987b. Effects of manganese oxide on monkeys as revealed by a combined neurochemical, histological and neurophysiological evaluation. Arch. Toxicol. 61:46-52.
32. Eriksson, H,, Gillberg, P. G., Aquilonius, S. M., Hedstrom, K. G., and Heilbronn, E. 1992a. Receptor alterations in manganese intoxicated monkeys. Arch. Toxicol. 66:359-364.
33. Eriksson, H., Tedroff, J., Thuomas, K. A., Aquilonius, S. M., Hartvig, P., Fasth, K. J., Bjurling, P., Langstrom, B., Hedstrom, K. G., and Heilbronn, E. 1992b. Manganese induced brain lesions in Macaca fascicularis as revealed by positron emission tomography and magnetic resonance imaging. Arch. Toxicol. 66:403-407.
34. Frumkin, H., and Solomon, G. 1997. Manganese in the U.S. gasoline supply. Am. J. Ind. Med. 31:107-115.
35. Gianutsos, G., and Murray, M. T. 1982. Alterations in brain dopamine and GABA following inorganic or organic manganese administration. Neurotoxicology 3:75-81.
36. Gorell, J. M., Johnson, C. C., Rybicki, B. A., Peterson, E. L., Kortsha, G. X., Brown, G. G., and Richardson, R. J. 1999. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology 20:239-247.
37. Gupta, S. K., Murthy, R. C., and Chandra, S. V. 1980. Neuromelanin in manganese-exposed primates. Toxicol. Lett. 6:17-20.
38. Gwiazda, R. H., Lee, D., Sheridan, J., and Smith, D. R. 2002. Low cumulative manganese exposure affects striatal GABA but not dopamine. Neurotoxicology 23:69-76.
39. Henriksson, J., and Tjalve, H. 2000. Manganese taken up into the CNS via the olfactory pathway in rats affects astrocytes. Toxicol. Sci. 55:392-398.
40. Huang, C. C., Chu, N. S., Lu, C. S., Wang, J. D., Tsai, J. L., Tzeng, J. L., Wolters, E. C., and Calne, D. B. 1989. Chronic manganese intoxication. Arch. Neurol. 46:1104-1106.
41. Huang, C. C., Lu, C. S., Chu, N. S., Hochberg, F., Lilienfeld, D., Olanow, W., and Calne, D. B. 1993. Progression after chronic manganese exposure. Neurology 43:1479-1483.
42. Hudnell, H. K. 1999. Effects from environmental Mn exposures: A review of the evidence from nonoccupational exposure studies. Neurotoxicology 20:379-397.
43. Iregren, A. 1990. Psychological test performance in foundry workers exposed to low levels of manganese. Neurotoxicol. Teratol. 12:673-675.
44. Iregren, A. 1999. Manganese neurotoxicity in industrial exposures: proof of effects, critical exposure level, and sensitive tests. Neurotoxicology 20:315-323.
45. Kennedy, G., and Valentine, R. 1994. Inhalation Toxicology. In Principles and methods of toxicology, ed. A. W. Hayes, pp. 805-838. New York: Raven Press.
46. Kim, E., Kim, Y., Cheong, H. K., Cho, S., Shin, Y. C., Sakong, J., Kim, K. S., Yang, J. S., Jin, Y. W., and Kang, S. K. 2005. Pallidal index on MRI as a target organ dose of manganese: Structural equation model analysis. Neurotoxicology 26:351-359.
47. Koller, W. C., Lyons, K. E., and Truly, W. 2004. Effect of levodopa treatment for parkinsonism in welders: A double-blind study. Neurology 62:730-733.
48. Komura, J., and Sakamoto, M. 1992. Effects of manganese forms on biogenic amines in the brain and behavioral alterations in the mouse - Long-term oral administration of several manganese compounds. Environ. Res. 57:34-44.
49. Kondakis, X. G., Makris, N., Leotsinidis, M., Prinou, M., and Papapetropoulos, T. 1989. Possible health effects of high manganese concentration in drinking water. Arch. Environ. Health 44:175-178.
50. Kosicka, B., Bugera, T. E., Czlonkowski, A., and Smialek, M. 1983. [Effect of experimental manganese chloride poisoning on the gamma-aminobutyric acid (GABA) content and dopaminergic receptor D-2 of the rat brain. Preliminary report], in polish. Neuropatol. Pol. 21:411-418.
51. Lewis, J., Bench, G., Myers, O., Tinner, B., Staines, W., Barr, E., Divine, K. K., Barrington, W., and Karlsson, J. 2005. Trigeminal uptake and clearance of inhaled manganese chloride in rats and mice. Neurotoxicology 26:113-123.
52. Lipe, G. W., Duhart, H., Newport, G. D., Slikker, W., and Ali, S. F. 1999. Effect of manganese on the concentration of amino acids in different regions of the rat brain. J. Environ. Sci. Health B Pestic. 34:119-132.
53. Lu, C. S., Huang, C. C., Chu, N. S., and Calne, D. B. 1994. Levodopa failure in chronic manganism. Neurology 44:1600-1602.
54. Lucchini, R., Selis, L., Folli, D., Apostoli, P., Mutti, A., Vanoni, O., Iregren, A., and Alessio, L. 1995. Neurobehavioral effects of manganese in workers from a ferroalloy plant after temporary cessation of exposure. Scand. J. Work Environ. Health 21:143-149.
55. Lucchini, R., Apostoli, P., Perrone, C., Placidi, D., Albini, E., Migliorati, P., Mergler, D., Sassine, M. P., Palmi, S., and Alessio, L. 1999. Long term exposure to "low levels" of manganese oxides and neurofunctional changes in ferroalloy workers. Neurotoxicology 20:287-297.
56. Lucchini, R., Benedetti, L., Borghesi, S., Garattini, S., Parrinello, G., and Alessio, L. 2003. Exposure to neurotoxic metals and prevalence of parkinsonian syndrome in the area of Brescia. G. Ital. Med. Lav. Ergon. 25(suppl.):88-89.
57. Lyznicki, J. M., Karlan, M. S., and Khan, M. K. 1999. Manganese in gasoline. Council on Scientific Affairs, American Medical Association. J. Occup. Environ. Med. 41:140-143.
58. Mella, H. 1924. The experimental production of basal ganglia symptomatology in macacus rhesus. Arch. Neurol. Psychiat. 11:405-417.
59. Mena, I., Court, J., Fuenzalida, S., Papavasiliou, P. S., and Cotzias, G. C. 1970. Modification of chronic manganese poisoning. Treatment with L-dopa or 5-OH tryptophan. N. Engl. J. Med. 282:5-10.
60. Mergler, D. 1999. Neurotoxic effects of low level exposure to manganese in human populations. Environ. Res. 80:99-102.
61. Mergler, D., and Baldwin, M. 1997. Early manifestations of manganese neurotoxicity in humans: An update. Environ. Res. 73:92-100.
62. Mergler, D., Huel, G., Bowler, R., Iregren, A., Belanger, S., Baldwin, M., Tardif, R., Smargiassi, A., and Martin, L. 1994. Nervous system dysfunction among workers with long-term exposure to manganese. Environ. Res. 64:151-180.
63. Mergler, D., Baldwin, M., Belanger, S., Larribe, F., Beuter, A., Bowler, R., Panisset, M., Edwards, R., de Geoffroy, A., Sassine, M. P., and Hudnell, K. 1999. Manganese neurotoxicity, a continuum of dysfunction: results from a community based study. Neurotoxicology 20:327-342.
64. Molders, N., Schilling, P. J., Wong, J., Roos, J. W., and Smith, I. L. 2001. Xray fluorescence mapping and micro-XANES spectroscopic characterization of exhaust particulates emitted from auto engines burning MMTadded gasoline. Environ. Sci. Technol. 35:3122-3129.
65. Montes, S., Alcaraz-Zubeldia, M., Muriel, P., and Rios, C. 2001. Striatal manganese accumulation induces changes in dopamine metabolism in the cirrhotic rat. Brain Res. 891:123-129.
66. 2) in the adult mouse. Neurotoxicology 6:1-15.
67. Nachtman, J. P., Tubben, R. E., and Commissaris, R. L. 1986. Behavioral effects of chronic manganese administration in rats: Locomotor activity studies. Neurobehav. Toxicol. Teratol. 8:711-715.
68. Neff, N. H., Barrett, R. E., and Costa, E. 1969. Selective depletion of caudate nucleus dopamine and serotonin during chronic manganese dioxide administration to squirrel monkeys. Experientia 25:1140-1141.
69. Newland, M. C. 1999. Animal models of manganese's neurotoxicity. Neurotoxicology 20:415-432.
70. Newland, M. C., and Weiss, B. 1992. Persistent effects of manganese on effortful responding and their relationship to manganese accumulation in the primate globus pallidus. Toxicol. Appl. Pharmacol. 113:87-97.
71. Newland, M. C., Ceckler, T. L., Kordower, J. H., and Weiss, B. 1989. Visualizing manganese in the primate basal ganglia with magnetic resonance imaging. Exp. Neurol. 106:251-258.
72. Nishiyama, K., Suzuki, Y., Fujii, N., Yano, H., Ohnishi, K., and Miyai, T. 1977. Biochemical changes and manganese distribution in monkeys exposed to manganese dioxide dust. Tokushima J. Exp. Med. 24:137-145.
73. Normandin, L., Ann Beaupre, L., Salehi, F., St-Pierre, A., Kennedy, G., Mergler, D., Butterworth, R. .F, Philippe, S., and Zayed, J. 2004. Manganese distribution in the brain and neurobehavioral changes following inhalation exposure of rats to three chemical forms of manganese. Neurotoxicology 25:433-441.
74. Normandin, L., Carrier, G., Gardiner, P. F., Kennedy, G., Hazell, A. S., Mergler, D., Butterworth, R. F., Philippe, S., and Zayed, J. 2002. Assessment of bioaccumulation, neuropathology, and neurobehavior following subchronic (90 days) inhalation in Sprague-Dawley rats exposed to manganese phosphate. Toxicol. Appl. Pharmacol. 183:135-145.
75. Olanow, C. W., Good, P. F., Shinotoh, H., Hewitt, K. A., Vingerhoets, F., Snow, B. J., Beal, M. F., Calne, D. B., and Perl, D. P. 1996. Manganese intoxication in the rhesus monkey - A clinical, imaging, pathologic, and biochemical study. Neurology 46:492-498.
76. Pentschew, A., Ebner, F. F, and Kovatch, R. M. 1963. Experimental manganese encephalopathy in monkeys. A preliminary report. J. Neuropathol. Exp. Neurol. 22:488-499.
77. Racette, B. A., Tabbal, S. D., Jennings, D., Good, L., Perlmutter, J. S., and Evanoff, B. 2005a. Prevalence of Parkinsonism and relationship to exposure in a large sample of Alabama welders. Neurology 64:230-235.
78. 18F]FDOPA PET and clinical features in Parkinsonism due to manganism. Mov. Disord. 20:492-496.
79. Ressler, T., Wong, J., and Roos, J. 1999. Manganese speciation in exhaust particulates of automobiles using MMT-containing gasoline. J. Synchrotron Radiat. 6:656-658.
80. Rodier, J. 1955. Manganese poisoning in Moroccan miners. Br. J. Ind. Med. 12:21-35.
81. Roels, H., Lauwerys, R., Genet, P., Sarhan, M. J., de Fays, M., Hanotiau, I., and Buchet, J. P. 1987. Relationship between external and internal parameters of exposure to manganese in workers from a manganese oxide and salt producing plant. Am. J. Ind. Med. 11:297-305.
82. 2) on the absorption and cerebral distribution of manganese in rats. Arch. Toxicol. 71:223-230.
83. Roels, H. A., Ghyselen, P., Buchet, J. P, Ceulemans, E., and Lauwerys, R. R. 1992. Assessment of the permissible exposure level to manganese in workers exposed to manganese dioxide dust. Br. J. Ind. Med. 49:25-34.
84. Rollin, H., Mathee, A., Levin, J., Theodorou, P., and Wewers, F. 2005. Blood manganese concentrations among first-grade schoolchildren in two South African cities. Environ. Res. 97:93-99.
85. Rosenstock, H. A., Simons, D. G., and Meyer, J. S. 1971. Chronic manganism. Neurologic and laboratory studies during treatment with levodopa. J. Am. Med. Assoc. 217:1354-1358.
86. Salehi, F., Krewski, D., Mergler, D., Normandin, L., Kennedy, G., Philippe, S., and Zayed, J. 2003. Bioaccumulation and locomotor effects of manganese phosphate/sulfate mixture in Sprague-Dawley rats following subchronic (90 days) inhalation exposure. Toxicol. Appl. Pharmacol. 191:264-271.
87. Sharp, P. E., and LaRegina, M. C. 1998. The laboratory rat. A volume in the laboratory animal pocket reference series. Boca Raton, FL: CRC Press.
88. Shinotoh, H., Snow, B. J., Hewitt, K. A., Pate, B. D., Doudet, D., Nugent, R., Perl, D. P., Olanow, W., and Calne, D. B. 1995. MRI and PET studies of manganese-Iintoxicated monkeys. Neurology 45:1199-1204.
89. Shinotoh, H., Snow, B. J., Chu, N. S., Huang, C. C., Lu, C. S., Lee, C., Takahashi, H., and Caine, D. B. 1997. Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication: A positron emission tomography study. Neurology 48:1053-1056.
90. Shukla, G. S., and Chandra, S. V. 1981. Striatal dopamine turnover and L-dopa treatment after short-term exposure of rats to manganese. Arch. Toxicol. 47:191-196.
91. Spadoni, F., Stefani, A., Morello, M., Lavaroni, F., Giacomini, P., and Sancesario, G. 2000. Selective vulnerability of pallidal neurons in the early phases of manganese intoxication. Exp. Brain Res. 135:544-551.
92. St-Pierre, A., Normandin, L., Carrier, G., Kennedy, G., Butterworth, R., and Zayed, J. 2001. Bioaccumulation and locomotor effect of manganese dust in rats. Inhal. Toxicol. 13:623-632.
93. Subhash, M. N., and Padmashree, T. S. 1990. Regional distribution of dopamine beta-hydroxylase and monoamine oxidase in the brains of rats exposed to manganese. Food Chem. Toxicol. 28:567-570.
94. Subhash, M. N., and Padmashree, T. S. 1991. Effect of manganese on biogenic amine metabolism in regions of the rat brain. Food Chem. Toxicol. 29:579-582.
95. Suzuki, Y., Mouri, T., Nishiyama, K., and Fujii, N. 1975. Study of subacute toxicity of manganese dioxide in monkeys. Tokushima J. Exp. Med. 22:5-10.
96. Talavera, E. J., Arcaya, J. L., Giraldoth, D., Suarez, J., and Bonilla, E. 1999. Decrease in spontaneous motor activity and in brain lipid peroxidation in manganese and melatonin treated mice. Neurochem. Res. 24:705-708.
97. Tanaka, S., and Lieben, J. 1969. Manganese poisoning and exposure in Pennsylvania. Arch. Environ. Health 19:674-684.
98. Tapin, D., Kennedy, G., Lambert, J., and Zayed, J. 2005. Bioaccumulation and locomotor effects of manganese sulfate in Sprague-Dawley rats following subchronic (90 days) inhalation exposure. Toxicol. Appl. Pharmacol. 211:166-174.
99. Thibault, C., Kennedy, G., Gareau, L., and Zayed, J. 2002. Preliminary assessment of atmospheric methylcyclopentadienyl manganese tricarbonyl and particulate manganese in selected urban sites. J. Toxicol. Environ. Health A 65:503-511.
100. Ulrich, C. E., Monaco, R. A., and Messer, S. M. 1977. Baseline pulmonary physiologic values for the squirrel monkey (Saimiri sciureus). Lab. Anim. Sci. 27:1024-1027.
101. Ulrich, C. E., Rinehart, W., and Brandt, M. 1979a. Evaluation of the chronic inhalation toxicity of a manganese oxide aerosol. III. Pulmonary function, electromyograms, limb tremor, and tissue manganese data. Am. Ind. Hyg. Assoc. J. 40:349-353.
102. Ulrich, C. E., Rinehart, W., and Busey, W. 1979b. Evaluation of the chronic inhalation toxicity of a manganese oxide aerosol - I. Introduction, experimental design, and aerosol generation methods. 40:238-244.
103. Ulrich, C. E., Rinehart, W., Busey, W., and Dorato, M. A. 1979c. Evaluation of the chronic inhalation toxocity of a manganese oxide aerosol. II. Clinical observations, hematology, clinical chemistry and histopathology. Am. Ind. Hyg. Assoc. J. 40:322-329.
104. U. S. Environmental Protection Agency. 2004. An examination of EPA risk assessments and practices. EPA/100/B-04/001. Washington, DC: Office of the Science Advisor, U.S. Environmental Protection Agency.
105. Van Bogaert, L., and Dallemagne, M. J. 1946. Approches experimentales des troubles nerveux du manganisme. Monatisshrift. Psychiat. Neurol. 111/112:61-89.
106. Vitarella, D., Wong, B. A., Moss, O. R., and Dorman, D. C. 2000. Pharmacokinetics of inhaled manganese phosphate in male Sprague-Dawley rats following subacute (14-day) exposure. Toxicol. Appl. Pharmacol. 163:279-285.
107. Weast, R. C., ed. 1985. Handbook of chemistry and physics, 65th ed. Boca Raton, FL: CRC Press.
108. Weigand, E., Kirchgessner, M., and Helbig, U. 1986. True absorption and endogenous fecal excretion of manganese in relation to its dietary supply in growing rats. Biol. Trace Elem. Res. 10:265-279.
109. Witholt, R., Gwiazda, R. H., and Smith, D. R. 2000. The neurobehavioral effects of subchronic manganese exposure in the presence and absence of pre-Parkinsonism. Neurotoxicol. Teratol. 22:851-861.
110. Wood, G. C., and Egyed, M. 1994. Risk assessment for the combustion products of methylcyclopentadienyl manganese tricarbonyl (MMT) in gasoline. Ottawa: Environmental Health Directorate, Health Canada.
111. Zayed, J. 2001. Use of MMT in Canadian gasoline: Health and environment issues. Am. J. Ind. Med. 39:426-433.